未登录

I

Inkeun Park

Asan Medical Center

H指数:28

被引数:2,869

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Body composition and immunotherapy outcomes in patients with advanced urothelial carcinoma

晚期尿路上皮癌患者的体成分与免疫治疗效果

IF3.4

2025-12-030

OAAI

Proteogenomic profiling predicts outcomes of adjuvant chemotherapy in extrahepatic cholangiocarcinoma

蛋白质组学分析预测肝外胆管癌辅助化疗的疗效

Journal of Hepatology

IF33

2025-08-110

PRE

Molecular profile and clinical impact of MDM2 amplification in patients with advanced biliary tract cancer

MDM2扩增在晚期胆道癌患者中的分子特征及临床影响

IF8.3

2025-07-310

PREAI

Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancreatic adenocarcinoma (NASOX): A multicenter phase I/IIa study

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-09-010

PRE

Metabolic tumor burden as a prognostic indicator after neoadjuvant chemotherapy in pancreatic cancer

INTERNATIONAL JOURNAL OF SURGERY

IF10.1

2024-07-011

OAAI

Comprehensive proteogenomic profiling and biomarker analyses in resected extrahepatic cholangiocarcinoma: A prespecified exploratory analysis of the phase 2 STAMP trial

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Pexa-vec (thymidine kinase-deactivated vaccinia virus plus GM-CSF) in combination with cemiplimab (REGN2810; ANTIPD-1) for metastatic or unresectable renal cell carcinoma REN026: Results from a phase II study

ANNALS OF ONCOLOGY

IF65.4

2023-10-011

OAAI

Impact of carbapenem-targeted antimicrobial stewardship interventions: an interrupted time-series analysis

碳青霉烯靶向抗菌药物管理干预措施的影响: 一项中断的时间序列分析

JOURNAL OF HOSPITAL INFECTION

IF3.1

2023-10-011

PRE

Prediction of conversion surgery completion following neoadjuvant modified FOLFIRINOX in borderline resectable and locally advanced pancreatic adenocarcinoma: machine learning algorithm analysis

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Spatial analysis of tumor-infiltrating lymphocytes in tumor microenvironment as biomarker for immune checkpoint inhibition in biliary tract cancer

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Enfortumab vedotin-related pneumonitis is more common than expected and could lead to acute respiratory failure

恩福妥维单抗相关性肺炎的发生率高于预期，可能导致急性呼吸衰竭。

EUROPEAN JOURNAL OF CANCER

IF7.1

2022-10-0113

PRE

AHCC®, a Standardized Extract of Cultured Lentinula Edodes Mycelia, Promotes the Anti-Tumor Effect of Dual Immune Checkpoint Blockade Effect in Murine Colon Cancer

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-04-207

OAAI

Genotypic and Phenotypic Characteristics of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Korean Patients

ANNALS OF LABORATORY MEDICINE

IF3.9

2021-03-018

OAAI

Gemcitabine plus carboplatin versus gemcitabine plus oxaliplatin in cisplatin-unfit patients with advanced urothelial carcinoma: a randomised phase II study (COACH, KCSG GU10-16)

EUROPEAN JOURNAL OF CANCER

IF7.1

2020-03-0112

PREAI

A multicenter, prospective phase II trial of gemcitabine plus axitinib in patients with renal cell carcinoma with a predominant sarcomatoid component

INVESTIGATIONAL NEW DRUGS

IF2.7

2019-06-244

PREAI

FGF19-FGFR4 Signaling in Hepatocellular Carcinoma

肝细胞癌中的FGF19-FGFR4信号传导

IF5.2

2019-06-04121

OAAI

FGFR1 expression defines clinically distinct subtypes in pancreatic cancer

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2018-12-2820

OAAI

C16-ceramide and sphingosine 1-phosphate/S1PR2 have opposite effects on cell growth through mTOR signaling pathway regulation

C16-ceramide和1-磷酸鞘氨醇/S1PR2通过mTOR信号通路调控对细胞生长具有相反的作用

ONCOLOGY REPORTS

IF3.9

2018-09-0715

OAAI

RandomizEd phase II trial of Sunitinib four weeks on and two weeks off versus Two weeks on and One week off in metastatic clear-cell type REnal cell carcinoma: RESTORE trial

ANNALS OF ONCOLOGY

IF65.4

2015-11-0190

PREAI

Risk factors for selection of patients at high risk of recurrence or death after complete surgical resection in stage I gastric cancer

IF5.1

2015-01-2339

OAAI